The world’s first genetically edited polo horses are here, all thanks to the efforts of a biotech firm based in Argentina.

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings ...

INVAMED Honored as "Medical Device Innovator of the Year 2025" by Global Health & Pharma for Pioneering AI-Driven Healthcare ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Watch IZomato rebrands to Eternal, ITC eyes frozen food, and Tata Power revives Trombay unit. See key stock trends!

Q2 2025 Earnings Conference Call February 6, 2025 5:00 PM ETCompany ParticipantsZane Keller - Director, IRMax Levchin ...

Highlights,IGM Biosciences has received a mix of evaluations from financial institutions, with varying perspectives on its market position.,Institutional investors continue adjusting their stakes, ...